Budget impact analysis of routinely using whole-genomic sequencing of six multidrug-resistant bacterial pathogens in Queensland, Australia.
Louisa G GordonThomas M ElliottBrian M FordeBrett G MitchellPhilip L RussoDavid L PatersonPatrick N A HarrisPublished in: BMJ open (2021)
Compared with standard of care, WGS surveillance at a state-wide level could prevent a substantial number of hospital patients infected with multidrug-resistant organisms and related deaths and save healthcare costs. Primary prevention through routine use of WGS is an investment priority for the control of serious hospital-associated infections.
Keyphrases
- antimicrobial resistance
- multidrug resistant
- healthcare
- gram negative
- drug resistant
- end stage renal disease
- acinetobacter baumannii
- ejection fraction
- public health
- palliative care
- chronic kidney disease
- klebsiella pneumoniae
- adverse drug
- peritoneal dialysis
- escherichia coli
- pain management
- patient reported outcomes
- pseudomonas aeruginosa
- dna methylation
- quality improvement
- patient reported